Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Non-Erosive Gastro-Esophageal Reflux Disease
Clinical Trial
NCT05195528Last updated: 12/4/2025
PHAT
Phathom Pharmaceuticals, Inc.
